This article is a correction to:
Beneficial Effect of Heat-Killed Lactiplantibacillus plantarum L-137 on Skin Functions in Healthy Participants: A Randomized, Placebo-Controlled, Double-Blind Study
Rieko YoshitakeHiroko NakaiManato EbinaKengo KawasakiShinji MurosakiYoshitaka Hirose*- Research and Development Institute, House Wellness Foods Corp., Itami, Japan
by Yoshitake, R., Nakai, H., Ebina, M., Kawasaki, K., Murosaki, S., and Hirose, Y. (2022). Front. Med. 9:912280. doi: 10.3389/fmed.2022.912280
In the published article, there was an error in the legend and footnote for Table 2 as published. The strain's name of lactic acid bacteria was described as “Lactiplantibacillus L-137.” The correct name is “Lactiplantibacillus plantarum L-137.” The correct legend and footnote appears below.
TABLE 2
Table 2. Effects of heat-killed Lactiplantibacillus plantarum L-137 on the water content of the stratum corneum and transepidermal water loss of the skin.
In the published article, there was an error in Table 2 as published. The value of ΔTEWL at the forearm, g/h m2 in the HK L-137 group at 4 weeks was incorrectly listed as “−2.91 ±1.33.” The correct value is “−0.91 ±1.33.” The corrected Table 2 and its caption appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: probiotics, immune function, gut-skin axis, water content, skin barrier, quality of life
Citation: Yoshitake R, Nakai H, Ebina M, Kawasaki K, Murosaki S and Hirose Y (2022) Corrigendum: Beneficial effect of heat-killed Lactiplantibacillus plantarum L-137 on skin functions in healthy participants: A randomized, placebo-controlled, double-blind study. Front. Med. 9:1048906. doi: 10.3389/fmed.2022.1048906
Received: 20 September 2022; Accepted: 03 October 2022;
Published: 18 October 2022.
Edited and reviewed by: Robert Gniadecki, University of Alberta, Canada
Copyright © 2022 Yoshitake, Nakai, Ebina, Kawasaki, Murosaki and Hirose. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yoshitaka Hirose, SGlyb3NlX1lvc2hpdGFrYSYjeDAwMDQwO2hvdXNlLXdmLmNvLmpw